IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS - ANVISA Registration 10287411750

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411750 and manufactured by CELL MARQUE CORPORATION. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Jun 16, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including VENTANA MEDICAL SYSTEM, INC, LEICA BIOSYSTEMS NEWCASTLE LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.